ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,868,000 | -31.1% | 47,054 | -40.9% | 0.24% | -46.5% |
| Q1 2019 | $5,613,000 | +15.7% | 79,571 | -26.2% | 0.44% | +28.7% |
| Q4 2018 | $4,852,000 | +163.6% | 107,771 | +230.9% | 0.34% | +141.8% |
| Q3 2018 | $1,841,000 | +145.5% | 32,565 | +179.8% | 0.14% | +116.9% |
| Q4 2017 | $750,000 | -90.8% | 11,639 | -92.5% | 0.06% | -92.8% |
| Q3 2017 | $8,141,000 | +299.1% | 155,089 | +255.7% | 0.90% | +330.0% |
| Q2 2017 | $2,040,000 | – | 43,596 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |